[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection]

Area of Science:

• Neurology
• Integrative Medicine
• Acupuncture Research

Context:

• Multiple Sclerosis (MS) is a chronic neurological disease impacting daily life.
• Current treatments aim to manage symptoms and improve patient outcomes.
• Exploring novel therapeutic approaches is crucial for MS management.

Purpose:

• To evaluate the clinical efficacy of electroacupuncture (EA) and acupoint injection (AI) for treating MS.
• To compare the combined EA + AI therapy against EA alone.

Summary:

• A study randomized 40 MS patients into two groups: EA and EA + AI.
• The EA + AI group received mouse nerve growth factor injections alongside EA.
• Outcomes were assessed using the Activity of Daily Life (ADL) and Expanded Disability Status Score (EDSS).
• Both groups showed significant improvement (P < 0.01).
• The EA + AI group demonstrated better EDSS and Barthel index scores post-treatment compared to the EA group (P < 0.01).

Impact:

• EA and AI co-therapy effectively reduces disability in MS patients.
• The combined treatment enhances the quality of life for individuals with MS.
• This study highlights the synergistic effects of EA and AI in MS management.